Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development

Expert Rev Vaccines. 2006 Aug;5(4):505-16. doi: 10.1586/14760584.5.4.505.

Abstract

The definition of immune correlates of protection in HIV-1 infection is pivotal to the design of successful vaccine candidates and strategies. Although significant methodological and conceptual strides have been made in our understanding of HIV-specific cellular immunity, we have not yet defined those parameters that have a role in controlling the spread of HIV infection. This review discusses the basis of our understanding of HIV-specific cellular immunity and identifies its shortcomings. Furthermore, potential protective characteristics will be proposed that may ultimately be required for an effective vaccine designed to stimulate cellular immunity against HIV-1.

Publication types

  • Review

MeSH terms

  • AIDS Vaccines*
  • Acquired Immunodeficiency Syndrome / immunology*
  • Antibody Formation*
  • CD4-Positive T-Lymphocytes / immunology
  • Disease Progression
  • HIV Infections / immunology*
  • HIV Infections / physiopathology
  • HIV-1 / immunology
  • T-Lymphocytes / immunology*

Substances

  • AIDS Vaccines